Publication: Points to consider in the development of seed stocks of pluripotent stem cells for clinical applications: International Stem Cell Banking Initiative (ISCBI)
dc.contributor.author | P. W. Andrews | en_US |
dc.contributor.author | D. Baker | en_US |
dc.contributor.author | N. Benvinisty | en_US |
dc.contributor.author | B. Miranda | en_US |
dc.contributor.author | K. Bruce | en_US |
dc.contributor.author | O. Brüstle | en_US |
dc.contributor.author | M. Choi | en_US |
dc.contributor.author | Y. M. Choi | en_US |
dc.contributor.author | J. M. Crook | en_US |
dc.contributor.author | P. A. De Sousa | en_US |
dc.contributor.author | P. Dvorak | en_US |
dc.contributor.author | C. Freund | en_US |
dc.contributor.author | M. Firpo | en_US |
dc.contributor.author | M. K. Furue | en_US |
dc.contributor.author | P. Gokhale | en_US |
dc.contributor.author | H. Y. Ha | en_US |
dc.contributor.author | E. Han | en_US |
dc.contributor.author | S. Haupt | en_US |
dc.contributor.author | L. Healy | en_US |
dc.contributor.author | D. J. Hei | en_US |
dc.contributor.author | O. Hovatta | en_US |
dc.contributor.author | C. Hunt | en_US |
dc.contributor.author | S. M. Hwang | en_US |
dc.contributor.author | M. S. Inamdar | en_US |
dc.contributor.author | R. M. Isasi | en_US |
dc.contributor.author | M. Jaconi | en_US |
dc.contributor.author | V. Jekerle | en_US |
dc.contributor.author | P. Kamthorn | en_US |
dc.contributor.author | M. C. Kibbey | en_US |
dc.contributor.author | I. Knezevic | en_US |
dc.contributor.author | B. B. Knowles | en_US |
dc.contributor.author | S. K. Koo | en_US |
dc.contributor.author | Y. Laabi | en_US |
dc.contributor.author | L. Leopoldo | en_US |
dc.contributor.author | P. Liu | en_US |
dc.contributor.author | G. P. Lomax | en_US |
dc.contributor.author | J. F. Loring | en_US |
dc.contributor.author | T. E. Ludwig | en_US |
dc.contributor.author | K. Montgomery | en_US |
dc.contributor.author | C. Mummery | en_US |
dc.contributor.author | A. Nagy | en_US |
dc.contributor.author | Y. Nakamura | en_US |
dc.contributor.author | N. Nakatsuji | en_US |
dc.contributor.author | S. Oh | en_US |
dc.contributor.author | S. K. Oh | en_US |
dc.contributor.author | T. Otonkoski | en_US |
dc.contributor.author | M. Pera | en_US |
dc.contributor.author | M. Peschanski | en_US |
dc.contributor.author | P. Pranke | en_US |
dc.contributor.author | K. M. Rajala | en_US |
dc.contributor.author | M. Rao | en_US |
dc.contributor.author | R. Ruttachuk | en_US |
dc.contributor.author | B. Reubinoff | en_US |
dc.contributor.author | L. Ricco | en_US |
dc.contributor.author | H. Rooke | en_US |
dc.contributor.author | D. Sipp | en_US |
dc.contributor.author | G. N. Stacey | en_US |
dc.contributor.author | H. Suemori | en_US |
dc.contributor.author | T. A. Takahashi | en_US |
dc.contributor.author | K. Takada | en_US |
dc.contributor.author | S. Talib | en_US |
dc.contributor.author | S. Tannenbaum | en_US |
dc.contributor.author | B. Z. Yuan | en_US |
dc.contributor.author | F. Zeng | en_US |
dc.contributor.author | Q. Zhou | en_US |
dc.contributor.other | University of Sheffield | en_US |
dc.contributor.other | Hebrew University of Jerusalem | en_US |
dc.contributor.other | Biobank Andalousian Public Health System | en_US |
dc.contributor.other | Roslin Cells Ltd | en_US |
dc.contributor.other | Universitat Bonn | en_US |
dc.contributor.other | Ministry of Food and Drugs Safety (MFDS) (KFDA) | en_US |
dc.contributor.other | Seoul National University College of Medicine | en_US |
dc.contributor.other | University of Melbourne | en_US |
dc.contributor.other | University of Edinburgh | en_US |
dc.contributor.other | Masaryk University | en_US |
dc.contributor.other | Leiden University Medical Center - LUMC | en_US |
dc.contributor.other | University of Minnesota System | en_US |
dc.contributor.other | National Institute of Biomedical Innovation | en_US |
dc.contributor.other | Korea National Institute of Health | en_US |
dc.contributor.other | LIFE AND BRAIN GMBH | en_US |
dc.contributor.other | National Institute for Biological Standards and Control | en_US |
dc.contributor.other | Waisman Center | en_US |
dc.contributor.other | Karolinska Institutet | en_US |
dc.contributor.other | Bioresource Collection and Research Center | en_US |
dc.contributor.other | Jawaharlal Nehru Centre for Advanced Scientific Research | en_US |
dc.contributor.other | McGill University | en_US |
dc.contributor.other | Universite de Geneve | en_US |
dc.contributor.other | European Medicines Agency | en_US |
dc.contributor.other | Chulalogcorn University | en_US |
dc.contributor.other | United States Pharmacopeia | en_US |
dc.contributor.other | Organisation Mondiale de la Sante | en_US |
dc.contributor.other | Jackson Laboratory | en_US |
dc.contributor.other | Institut des Cellules Souches pour le Traitement et L'etude des Maladies Monogeniques | en_US |
dc.contributor.other | Andalousian Initiative Advanced Therapies (IATA | en_US |
dc.contributor.other | Wellcome Trust Sanger Institute | en_US |
dc.contributor.other | California Institute for Regenerative Medicine | en_US |
dc.contributor.other | Scripps Research Institute | en_US |
dc.contributor.other | WiCell Research Institute | en_US |
dc.contributor.other | The Lunenfeld-Tanenbaum Research Institute of University of Toronto | en_US |
dc.contributor.other | Riken BioResource Center | en_US |
dc.contributor.other | Kyoto University | en_US |
dc.contributor.other | Agency for Science, Technology and Research, Singapore | en_US |
dc.contributor.other | Helsingin Yliopisto | en_US |
dc.contributor.other | Universidade Federal do Rio Grande do Sul | en_US |
dc.contributor.other | Tampereen Yliopisto | en_US |
dc.contributor.other | The New York Stem Cell Foundation Research Institute | en_US |
dc.contributor.other | Hadassah University Medical Centre | en_US |
dc.contributor.other | International Society for Stem Cell Research | en_US |
dc.contributor.other | Riken Center for Developmental Biology | en_US |
dc.contributor.other | National Institutes for Food and Drug Control | en_US |
dc.contributor.other | Shanghai Jiao Tong University School of Medicine | en_US |
dc.contributor.other | Institute of Zoology Chinese Academy of Sciences | en_US |
dc.contributor.other | Mahidol University | en_US |
dc.date.accessioned | 2018-11-23T10:09:47Z | |
dc.date.available | 2018-11-23T10:09:47Z | |
dc.date.issued | 2015-01-01 | en_US |
dc.identifier.citation | Regenerative Medicine. Vol.10, (2015), 1-44 | en_US |
dc.identifier.doi | 10.2217/rme.14.93 | en_US |
dc.identifier.issn | 1746076X | en_US |
dc.identifier.issn | 17460751 | en_US |
dc.identifier.other | 2-s2.0-84923189564 | en_US |
dc.identifier.uri | https://repository.li.mahidol.ac.th/handle/123456789/35977 | |
dc.rights | Mahidol University | en_US |
dc.rights.holder | SCOPUS | en_US |
dc.source.uri | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84923189564&origin=inward | en_US |
dc.subject | Engineering | en_US |
dc.title | Points to consider in the development of seed stocks of pluripotent stem cells for clinical applications: International Stem Cell Banking Initiative (ISCBI) | en_US |
dc.type | Article | en_US |
dspace.entity.type | Publication | |
mu.datasource.scopus | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84923189564&origin=inward | en_US |